Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
What is Evoke Pharma's quote symbol?
What is the 52 week high and low for Evoke Pharma (NASDAQ: EVOK)?
How much is Evoke Pharma stock worth today?
How much is Evoke Pharma's stock price per share?
What is Evoke Pharma's Market Cap?